Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1681000188119 | afatinib | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 3488323016 | Product containing afatinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3713014013 | Afatinib-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 50014831000188118 | médicament contenant afatinib | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 734441000241110 | afatinib (produit médicinal) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| afatinib | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| afatinib | est un(e) (attribut) | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Some | ||
| afatinib | est un(e) (attribut) | Product containing protein-tyrosine kinase inhibitor (product) | true | Inferred relationship | Some | ||
| afatinib | a pour principe actif (attribut) | Afatinib (substance) | true | Inferred relationship | Some | 1 | |
| afatinib | est un(e) (attribut) | Medicinal product categorized by structure | false | Inferred relationship | Some | ||
| afatinib | est un(e) (attribut) | inhibiteur enzymatique | false | Inferred relationship | Some | ||
| afatinib | est un(e) (attribut) | Product containing quinazoline (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only afatinib (medicinal product) | est un(e) (attribut) | True | afatinib | Inferred relationship | Some | |
| Afatinib dimaleate 20 mg oral tablet | est un(e) (attribut) | False | afatinib | Inferred relationship | Some | |
| Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | False | afatinib | Inferred relationship | Some | |
| Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | False | afatinib | Inferred relationship | Some | |
| Afatinib-containing product in oral dose form | est un(e) (attribut) | True | afatinib | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR